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Abstract
Digestive endoscopy represents an essential diagnostic and curative tool used when
presented with a suspicion of gastrointestinal (GI) bleeding. Its role is not only
confined to primary detection but also to establishing the severity of a lesion and
providing relevant information regarding its risk of bleeding. New endoscopic
techniques, accessories and compounds make the minimally invasive treatment
suitable for a vast array of lesion types. Our main goal in this chapter is to summarize
the main presentation of lesions at risk of bleeding, briefly classify them according to
the gastrointestinal segment and finally detail the endoscopic treatment options
currently available.
Therapeutic endoscopy significantly reduced mortality from upper gastrointestinal
bleeding. Most common causes of lower gastrointestinal bleeding are: colon cancer,
diverticulosis, colon polyps, inflammatory bowel disease, hemorrhoids, anal fissures
and angiodysplasia. Digestive bleeding diagnosis strategy requires rapid clarification
of the following elements: recognition of gastrointestinal bleeding, specifying the
location of bleeding, assessment of its severity, specification of the etiology of bleeding
and patient’s risk factors. Early diagnosis of the cause of bleeding and endoscopic
hemostasis reduced the need for hospitalization, blood transfusions and emergency
surgery.
Keywords: endoscopic hemostasis, gastrointestinal, endoscopic treatment, colon
cancer
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1. Introduction
Digestive endoscopy represents an essential diagnostic and curative tool used when presented
with a suspicion of gastrointestinal (GI) bleeding. Its role is not only confined to primary
detection but also to establishing the severity of a lesion and providing relevant information
regarding its risk of bleeding. New endoscopic techniques, accessories and compounds make
the minimally invasive treatment suitable for a vast array of lesion types. Our main goal in
this chapter is to summarize the main presentation of lesions at risk of bleeding, briefly classify
them according to the gastrointestinal segment and finally detail the endoscopic treatment
options currently available.
2. Endoscopic semiology
In general, we can describe four main types of gastrointestinal lesions that may present a risk
of bleeding.
Hemorrhagic lesions are described as either active injury bleedings or the stigmata of bleeding.
The first type is found mainly as point hemorrhagic lesions that bleed. They appear in uremic
gastritis, some toxic or drug-induced gastritis. Bleeding stains are described as areas of 2-5 mm
in diameter, highlighted in alcohol or NSAIDs-induced gastropathies. A hemorrhagic area of
approximately 5-20 mm can present active bleeding, either diffuse, with areas of normal
mucosa, caused by capillary bleeding, or bleeding from a vessel [1], either continuous (vein)
or pulsating (arterial). The stigmata of bleeding persist after the bleeding has stopped, until full
healing occurs. Re-bleeding can be predicted from injuries: ulcers, varices, hemorrhagic erosive
gastritis [1-3].
They are described as petechial lesions (small hyperemic points that generally do not bleed),
bruising (blue area of the mucosa caused by extravasated blood) and blood clots (blood vessel
coated with a clot).
2.1. Flat lesions at risk of bleeding
The most commonly described is erythema, reddish appearance of the mucosa. Aftae are very
superficial erosions covered by fibrin debris with peripheral leukocytes and surrounded by
an intensely hyperemic halo. Deposits are usually purulent, a thin layer under which erosions
are usually found. Angiodysplasia lesions are dilated vascular structures, usually pulsatile,
and with multiple ramifications.
Vascular protrusions and protruding lesions at risk of bleeding are described as hemangio‐
mas - clusters of capillaries and veins produced by anarchic proliferation; varices - dilated
veins located in the submucosa, which protrude to the surface mucosa and have tortuous paths
[4] and polyps (polypoid lesions - Figure 1) that may have an ulcerated surface, covered with
detritus, or active bleeding.
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Figure 1. Bleeding polyp of the sigmoid
Excavated injury at risk of bleeding are either cracks, ulcerations or ulcers. Cracks are
extremely narrow linear ulcerations that generally go deep and may be covered by necrotic or
hemorrhagic debris. Ulcerations are superficial, up to 2 mm deep, with a more or less regular
outline, having a diameter of 4-5 mm; they are generally acute. The ulcer (niche) represents a
loss of substance above 2-3 mm, with generally well-cut edges. Their shape varies depending
on the age of the lesion.
3. Lesions at risk of bleeding
3.1. Esophageal lesions
Esophageal varices are venous dilatations that continue gastric coronary veins, piercing the
wall of the esophagus above the cardia or in the submucosa. They usually appear in portal
hypertension of any etiology. Their color varies with depth: the deepest appear white, while
superficial varicose veins display a more bluish hue.
The caliber of esophageal varices varies depending on peristalsis, being more turgid and more
tortuous during movement. The classical classification of esophageal varices identifies 5
degrees, depending on size: Ist grade - protrude into the lumen, veins are tortuous, with sizes
up to 1-1.5 mm; IInd grade have dimensions between 2 and 4 mm and 3-4 mm beyond the
mucosa plan; IIIrd grade are more turgid, have more than 5 mm in diameter and may occupy
half of the esophageal lumen; IVth grade varices are 6-7 mm in size, exceeding half of the
esophageal lumen, without occluding it; Vth grade are larger than 6-7 mm (giant varices) and
are extremely dilated, frequently occluding the lumen of the esophagus.
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3.1.1. Early esophageal cancer
Malignant lesions limited to the mucosa and submucosa, with or without lymph node
metastases. Upper endoscopy can highlight different aspects: background mucosa erosion,
surface hyperemia and erythema, slightly elevated plates with grainy surfaces, or confluent
plaques which give the appearance of “orange peel” edema and congestion as red spots that
bleed easily. Cancer superficial erosion is friable, bleeding when touched by the endoscope,
and represents the most common lesion. It can produce an enteric fistula with massive aortic
bleeding which is often fatal.
3.1.2. Candidal esophagitis
Flat lesions with very thick fibrin and leukocyte deposits; underneath, we can find granulation
tissue, hyperemia, spontaneous bleeding.
3.2. Pathology of the stomach
Congestive mucosa is characterized by hyperemia, edema and exudation; may be the result
of irritation, functional disorders and gastritis. It can appear as red freckles distributed
throughout the gastric mucosa; mosaic-like (multiple areas of erythema, bordered by a whitish
reticular network); cherry-red spots, representing confluent areas of diffuse bleeding; black-
brown spots representing hematin, indicating an old bleedings.
Hemorrhagic gastritis is defined by the presence of hemorrhagic spots, either as ecchymosis
areas or diffuse gastric bleeding.
3.3. Vascular abnormalities of the colon
Angiodysplasia is diagnosed especially in the elderly, often in the cecum and ascending colon.
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is characterized by
small lesions that are found on the skin, lips and the entire gastrointestinal tract.
Hemangiomatosis cavernous is a rare condition characterized by cavernous hemangiomas of
the skin and is bluish in color in the gastrointestinal tract, including the colon. Cavernous
hemangiomas may be located remote from the rectum.
Varices can be located on any segment of the colon or rectum, more frequently in patients with
portal hypertension. Varicose veins of the anorectal junction are considered hemorrhoids.
Ischemic colitis can sometimes be encountered during the diagnosis of acute rectal bleeding.
Endoscopic changes are varied and depend on the severity and duration of ischemia. Endos‐
copy finds pale mucosa with multiple petechiae and hemorrhagic necrosis of superficial areas.
Similar ulcers may occur in late Crohn's disease (Figure 2), only less deep. Usually, these cases
do not reach endoscopy as they present as an acute surgical abdomen, soliciting emergency
intervention.
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Figure 2. Crohn's disease
3.3.1. Bleeding after endoscopic procedures
Bleedings are rare and usually minor after gastrointestinal endoscopy diagnostic procedures,
unless associated with anticoagulant therapy, thrombocytopenia and portal hypertension.
Postbiopsy bleedings are minor and stop spontaneously. Upper endoscopy with biopsy
diagnosis is generally a safe procedure, even at a platelet count of 20,000/mmc; currently
available data suggest that anticoagulation therapeutic target in appropriate doses and
treatment with standard doses of NSAIDs are not associated with increased risk of bleeding.
However, both biopsy and therapeutic procedures should be avoided if the platelet count is
below 20,000/mmc or if the anticoagulant treatment is overdosed.
4. Endoscopic therapeutical options
4.1. Endoscopic hemostasis
Endoscopic hemostasis is one of the most common applications of interventional endoscopy
procedures [5], due to the bleeding frequency and vital digestive and immediate risk that these
entail. Endoscopic hemostasis requires techniques used in combination to stop gastrointestinal
bleeding. Correct identification of the source of bleeding is a very important step as approxi‐
mately 2% of lesions are not identified at the first endoscopy. Once the source of bleeding is
identified, the next step is the application technique and hemostasis and the initiation of the
pharmacological treatment. “Second-look” endoscopy, defined as endoscopic revaluation
24-48 hours after successful hemostasis, is a controversial practice.
The main techniques used for endoscopic treatment of digestive bleeding are: endoscopic
ligation, injection techniques (such as injection of adrenaline or of sclerosing substances);
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laser therapy; argon plasma; thermocoagulation; electrocoagulation; mechanical techni‐
ques (metal clips, sewing equipment or equipment for mechanical suture).
Endoscopic ligation is indicated in digestive bleeding caused by rupture of esophageal varices,
Dieulafoy’s lesions rupture of varices stomach (lower but effective). It is based on fitting a
Saeed ligator multiband type (4-6-8 ligatures) at the end of therapeutic endoscope before the
examination. Consists of a plastic cylinder that is fitted with elastic bands that are issued by
tractioning a wire (non-metal or metal) into the biopsy channel. Ligatures of the wire are at
risk of trauma on channel biopsy, although this risk is reduced. Complications are possible:
postligature ulcerations (higher risk for varicose gastric), bacteremia, postligature pain and
strictures.
Endoscopic sclerotherapy uses a wide range of sclerosing agents [6, 7]: 70 degrees alcohol or
absolute alcohol sodium morrhuate, ethanolamine oleate and polidocanol. The main indica‐
tion is represented by gastric or esophageal varices. Alcohol is cheaper, but most endoscopy
centers in developed countries are using polidocanol. To gastric varices, the preferred
technique is injecting N-butyl-2 cyanoacrylate histoacryl (super glue) through a special
catheter. The main risks are the pulmonary embolism, as well as sticking of the biopsy channel
of the catheter, which resulted in serious damage in endoscope and even irreversible. Varicose
esophageal varices may be associated with risk of stricture of bacteremia and chest pain.
Sclerosing technique is relatively as simple as endoscopic ligation. Varicose is done by entering
the sheath sclerotherapy biopsy channel, with the needle inside (to avoid damage to the biopsy
channel). At the end of the sheath when viewing off peak endoscope, remove the needle from
the sheath and inject about 1-2 ml tangent in variceal path immediately below the bleeding,
repeating the procedure in the four quadrants. The maneuver can be repeated if bleeding is
not found to stop within 1-2 minutes. Higher doses may be associated with local necrosis.
After the endoscope advances to the identified place, the endoscopist can place the tip of the
endoscope immediately in place, as close as possible to the variceal path of the ligation cylinder.
Maintaining aspiration, one can apply a ligature by tractioning the ligation wire, continuing
for 2-3 seconds after the aspiration application of the ligature. Then repeat the procedure in
the four quadrants and the variceal tracts projecting from the lower to the portion on top of
the esophagus.
Injection of hemostatic solutions is useful in gastric ulcers, duodenal or anastomotic, Mallory-
Weiss syndrome even more effective in bleeding tumors or bleeding Dieulafoy’s lesions
postpolipectomy [7]. The 1/10000 adrenaline solution used is prepared by diluting 1 ml
adrenaline in 1/1000 9 ml saline. The needle sheath channel biopsy is used as in sclerotherapy
of esophageal varices. Injection of adrenaline around the lesion is bleeding in all four quad‐
rants, starting with the most distal point. The favorable effect is visible through bleaching and
raising the lining around the area where the injection is stopping bleeding. Electrocoagulation
consists in the application of high-power frequency of the tissue directly, resulting in a local
heat of 100°C. Thus, the bleeding vessel is closed by coagulation necrosis of the surrounding
tissue and the vascular wall. Efficiency of the method is shown in 80-95% of patients. The
multipolar electrocoagulation version is the most common today, consisting of applying three
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equally spaced bipolar electrodes. Multipolar electrocoagulation eliminates some drawbacks
of proof pole as unpredictable depth of tissue damage, adherence of tissue and mobilization
of clots.
The effectiveness of coagulation is expressed by flattening or even depression visible vessel,
which indicates the need for pressure, otherwise rebleeding might occur. Both coagulation and
polypectomy require an endoscopy laboratory device electrosurgical cutting and coagulation
current. Thermocoagulation is defined as a source of bleeding and coagulation by means of an
aluminum spatula coated with Teflon. The tool can be irrigated with a jet of water to prevent
the accumulation of debris and tissue clots on it. The method of coagulation is similar to
electrocoagulation.
Mechanical techniques include applying metallic clips and use of sewing machines and
equipment for mechanical suture. The available applicators clips are placed on the biopsy
channel and are applied by pressing the clip, then applicator detachment clip applicator is
withdrawn, with the clip remaining at the bleeding.
The primary indication is bleeding from larger vessels, but can be used for closure of holes or
iatrogenic postpolipectomy perforation. Both for hemostasis as well as for the treatment of
perforations recommend using multiple clips at the same lesion site.
Argon plasma coagulation (APC) requires argon plasma apparatus with argon cylinders.
Application is made from a distance of a few millimeters, without the need for direct contact
with the mucosa. Safe coagulation is possible because the effect is limited to 3 mm depth [8].
Introducing excess gas is one of the adverse effects. The major indication is represented by
angiodysplasia or diffuse bleeding from the rectum, but can also be used for palliative
purposes such as radical digestive tumors. Adenomatous tissue remnants can be destroyed,
postpolipectomy being useful in supplementing it. The laser can stop the bleeding by vaso‐
constrictive properties associated with protein wall degradation and dehydration, but its use
in endoscopic hemostasis is reduced.
5. Endoscopic treatment of some of the most prominent gastrointestinal
bleedings
5.1. Endoscopic treatment of variceal bleeding
Endoscopic sclerotherapy involves injecting sclerosing substances that cause coagulation
necrosis and induces instantaneous and local thrombosis. Endoscopic sclerotherapy is superior
to conservative measures, with a success rate of about 90% for the control of variceal bleeding;
early rebleeding frequency decreases and increases survival [9].
Thrombosis of esophageal varices is achieved by endoscopic injection of sclerotic agents
(absolute alcohol, sodium morrhuate 5%, ethanolamine oleate 5-10%, 1-2% sodium tetradecyl
sulfate) just above the esogastric junction. Paravariceal injections are performed, both intra‐
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variceal or combinations. Comparative studies of the effectiveness of different substances are
numerous, but the relative effectiveness of different substances is not clear.
The risk of rebleeding and complications is high. The most common cause of esophageal ulcers
appears to be massive rebleeding and mortality of 2-3%. Almost all patients have fever,
transient dysphagia and chest pain. Other possible complications are chest pain, aspiration
pneumonia, pleural effusions and mediastinitis [10, 11]. Frequency of complications depends
on the experience of the operator and is proportional to the amount of sclerosant injected; and
mortality induced complications are between 2-5%.
Endoscopic variceal ligation uses small rubber rings or strips of nylon for varicose veins
occlusion, promoting hemostasis by physical contraction, followed by local thrombosis.
Ligation with multiple lanes is used which allows strangulation of esophageal tract, followed
by local necrosis. Variceal path is drawn in clear plastic a cylinder loaded with elastic bands,
followed by the release of the first bands. The effectiveness of elastic ligatures is similar to
sclerotherapy to control acute bleeding esophageal varices rupture, the success rate of
approximately 90%. The number of sessions required for eradication is significantly lower
compared with sclerotherapy.
Complications are significantly reduced and mainly consist of dysphagia or esophageal ulcers.
However, esophageal ulcers laid after ligation tend to be small, with low risk of perforation
and strictures. Aspiration pneumonia is a complication of endoscopic examination in the
context of upper gastrointestinal bleeding [12]. A recently described complication consisted of
ligation circumference esophageal strictures after pushing to form a band with the endoscope
into the stomach [13].
Compared with sclerotherapy, endoscopic ligation gives better results in terms of frequency
of complications, prolonged survival but also a better control of active bleeding [14-16]. Meta-
analysis of published studies demonstrated that esophageal varices ligatures are significantly
more effective than sclerotherapy variceal rebleeding prevention, with fewer sessions needed
on average for eradication and fewer major complications [17]. Endoscopic ligation efficiency
of endoscopic sclerotherapyis superior to the use of somatostatin or octreotide drug therapy
[16, 17]. Usually, six elastic bands are used in the ligation sessions. Using a higher number of
bands is not associated with a higher efficiency and is accompanied by an increased time of
the procedure [18].
Endoscopic treatment by ligation of esophageal varices is more effective than medical therapy
in active variceal bleeding and to prevent early rebleeding [19]. Other options included the use
of cutouts (Endoloop) compared with elastic ligatures that appeared to have a similar efficiency
[20]. Plastic mini-loops (nylon) are passed through the biopsy channel and placed on the inside
of the cylinder. Similar elastic bands in variceal path are drawn into the transparent cylinder,
and then loop is detached and tightened. Similar elastic bands and sclerotherapy detachable
loops are associated with these possible complications: esophageal ulcers laid, laid pierce,
strictures and infections. Although the authors consider cutouts as an option compared to
treatment with elastic ligatures, this method has not gained popularity due to technical
difficulties using cutouts in acute hemorrhage.
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5.2. Gastric varices
In esogastric varices Type I (continuation of esophageal along the lesser curve gastric),
treatment should be similar to HDS treatment of esophageal varices rupture. If gastric varices
are isolated using adhesive agents (N-butylcyanoacrylate, isobutyl-2-cyanoacrylate and
thrombin), endoscopic ligation compared with sclerotherapy and alcohol is superior to a better
initial control of bleeding and rebleeding rate of less [21, 22]. In a recent pilot study of a new
adhesive agent, 2-octyl cyanoacrylate appears to be as effective in obtaining hemostasis and
prevents rebleeding from initial background varices [23].
Other invasive treatments (TIPS, surgical shunts, splenectomy, retrograde transvenous
obliteration balloon occlusion) are still used. An attractive option was to use elastic ligatures
or cutouts, which are being evaluated, taking into account the low efficiency of sclerotherapy.
Endoscopic obstruction by 2-cyanoacrylate isobutyl (bucrylate) or 2-cyanoacrylate N-butyl-
(histoacryl) is used for large esophageal or gastric varices. The mechanism of action consists
in polymerization and rapid solidification after intravariceal injection. Complications include
emboli (lung, kidney, brain, etc.) in up to 5% of the patients, the passage of the adhesive through
the inferior vena cava or gastrorenal or damage to the endoscope (channel occlusion) or needle
impaction varices. Dilution with lipiodol is preferred since the polymerization process delays
by 20 sec [24].
In the absence of tissue adhesives, conventional endoscopic techniques involve the use of
elastic ligatures with or without combinations with sclerotherapy. Sclerotherapy classic
sclerosing substance is not currently listed, complications are due to large and high frequency
of severe and fatal rebleeding [24]. Elastic ligatures combined use of sclerotherapy with
cyanoacrylate seems to be superior to simple methods [25, 26].
Combined treatment (ligatures + sclerotherapy) in patients with gastric variceal bleeding assets
seems very promising, 100% taking into account initial hemostasis (after ligation and injection
of 1% polidocanolinto the neighboring submucosa) [27]. These promising results will be
confirmed in prospective studies with large numbers of patients. Retrograde transvenous
obliteration occlusion balloon is a method recently used with good results in patients with
gastric and gastrorenalvarices [28, 29]. Left adrenal vein is cannulated through a retrograde
path from the right femoral vein or right internal jugular vein. After vein occlusion, left renal
venography is performed and sclerosating agents are injected (ethanolamine oleate) mixed
with iopamidol, with radiological control up to complete filling of gastric varices. Compared
to treatment with TIPS, transvenous obliteration has the same proportion of hemostasis,
rebleeding and encephalopathy, the major drawback being that it cannot be performed in
patients with gastrorenalvarices [18].
5.3. Non-variceal upper gastrointestinal bleedings
Endoscopic treatment allows definitive stop of active bleeding in over 90% of the cases [30-32].
Meta-analysis of published studies have clearly indicated that active bleeding stops endo‐
scopic treatment in most cases and significantly reduces the frequency of rebleeding, transfu‐
sion requirements, emergency surgical interventions and mortality [33-35]. Mortality is
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directly correlated with rebleeding, both dependent on different variables and clinical stigmata
of bleeding as defined by Forrest classification. A consensus was reached that endoscopic
treatment must be performed only in patients with increased risk of bleeding or rebleeding
and thus increased mortality [36].
Patients with active bleeding (Forrest Ia and b) and visible vessel (Forrest IIa) are treated by
endoscopy. Although initial studies recommended treatment of ulcers with adherent clot
(Forrest IIb), several recent studies have demonstrated these patients require treatment by
endoscopic removal of the adherent clot [37, 38]. Patients with pigment spots in the ulcer crater
(Forrest IIc) or clean base (Forrest III) did not receive endoscopic treatment; with a low
frequency of rebleeding, a proton pump inhibitor treatment is sufficient. Different endoscopic
hemostasis treatments are currently available for endoscopic hemostasis: injection (adrenaline
or sclerosing agents), thermal methods (argon plasma coagulation or multipolar) or mechan‐
ical methods (clips, ligatures elastic). The primary hemostasis is achieved in over 95% of cases,
rebleeding seen in 5-10% of patients, respectively mortality of approximately 5% [39]. How‐
ever, there is an extremely high variability of methods used and results obtained from different
centers, probably due to experienced endoscopists and risk category included for patients (age,
associated diseases, etc.) [40].
5.4. Hemostasis injection
Endoscopic hemostatic treatment by injection is applied using a metal retractable catheter
needle, which is inserted through the biopsy channel of the endoscope. Live view of the needle
tip allows precise positioning of endoscopic control. If the lesions are located at tangential face
of needle, the needle can be removed to cling to the lining and to facilitate positioning catheter.
Injection of epinephrine 1:10,000 is used frequently in ulcer bleeding but can be used on other
types of non-variceal lesions). Injection of epinephrine 1:10,000 has very few risks and
complications. The risk of perforation is also negligible. According to a recent study, it was
shown that injection of submucosa adrenaline can cause significant hemodynamic changes
that can lead to severe cardiac adverse effects [41]. In this regard, monitoring heart after
administration of epinephrine is the recommended cautious attitude more especially when
used in large doses. In the treatment of bleeding lesions, esophagus total dose of adrenaline
should be carefully titrated and should be used with a minimum dose that can achieve
hemostasis. Sclerosing substances are generally reserved for hemostasis in patients with
variceal bleeding, especially for esophageal varices. Histoacryl (N-butyl-2-cyanoacrylate) is a
tissue adhesive which instantly coagulates in contact with blood. Injection of the varices
histoacryl determines the solidification path of the variceal occlusion by inducing thrombosis
vein, being used mainly for gastric varices. Rubber band ligation is not effective in mucous
coating and is gradually affected by exulceration favoring the use of extrusion solidified
adhesive, with the emergence of a profound ulcer. The main complication consists of glue
embolization at brain and lung.
Thermal hemostasis methods can be divided into direct contact and non-contact thermal
coagulation. Non-contact coagulation refers to the use of laser treatment or argon plasma
coagulation jet. Coagulation is used in baked, i.e. non-variceal, hemorrhage when a vessel is
visible. There are significant differences between monopolar coagulation probes, bipolar and
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multipolar heater samples and the mechanism of action is similar [42]. Area bleeding or visible
vessel is compressed while applying electrical or thermal energy in pulses that lasts up to 8
consecutive seconds. The preferable accessories are large (3.2 mm) and a current of 15-25 W.
The application of thermal energy in the absence of compression of the vessel wall may worsen
breakthrough of bleeding vessel wall. The risk of perforation is substantially increased in acute
ulcers approached by thermal coagulation.
Argon plasma coagulation (APC) transmits heat to tissues through ionized gas and does not
require direct contact probe to target lesion. APC cannula is placed 1-2 mm distance from target
lesion and activated to induce coagulation of tissue surrounding surface. The risk of perfora‐
tion is lower, excluding attachment of the cannula tube to the wall tract. Argon plasma
coagulation is used for the treatment of superficial injury of vascular malformation type. In
addition, APC was elastic ligatures used in combination with secondary prophylaxis variceal
bleeding due to reduction of variceal recurrence. Although they are highly effective achieving
hemostasis, mechanical devices are extremely difficult to place in lesions that are difficult to
reach (small gastric curvature and posterior wall of the duodenum).
Metal clips are similar to surgical sutures and can be placed endoscopically under direct vision.
Two to five clips are generally placed for achieving hemostasis in the area of bleeding or visible
vessel. The main advantage lies in the absence of tissue damage and the possibility of using in
deep ulcers or large blood vessels. Videos can also be used to close small punctures on them,
although difficult to locate, especially when using tangential or ulcers central fibrosis.
Elastic ligatures are currently considered the treatment of choice for the rupture of esophageal
varices. Elastic ligatures are particularly effective for stopping jet bleeding (spurting), although
equally difficult to place in conditions like fibrosis of ulcers [43-45]. Placement is facilitated by
the injection of mucosa adrenaline 1:10,000. Both clips as well as elastic ligatures are relatively
easy to place and have good efficiency in cases of non-variceal HDS of due to non-ulcer:
Mallory-Weiss syndrome, arteriovenous malformations, Dieulafoy’s lesion, or bleeding
postpolipectomy, such as endoscopic mucosa resection [46-48]. Rebleeding seems to be greatly
reduced by using mechanical hemostasis (clips or ligatures) versus adrenaline injection in
patients with Dieulafoy’s lesions [49]. Removable clips were initially used to reduce bleeding
occurring after the resection of formations protruding the mucosa, tailored with a plastic
cylinder used for variceal bleeding. In patients with chronic colitis with HDS, non-variceal
hemostasis is more effective in combination by applying heat treatment and injection.
Hemostasis techniques may be ineffective in a variable number of cases. In these situations,
alternative techniques are used which include coagulation jet argon plasma (APC) or mechan‐
ical devices (metal clips, ligatures removable nylon elastic loops) [50-52]. Good results occur
after placement of the ligatures, elastic, in particular small lesions (Dieulafoy’s lesions,
hemangiomas, small ulcers <1 cm, etc.).
5.5. Rebleeding and “second-look” endoscopy
Active bleeding cannot be controlled by endoscopic and it requires emergency surgical
intervention [53]. Patients who rebleed after endoscopic treatment must repeat endoscopy to
confirm the source of bleeding and bleeding stigmata. After rebleeding, endoscopic retreat‐
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ment intervention is comparable to surgical prognosis [54]. The management of rebleeding
after endoscopic treatment and correct medical treatment depend largely on local expertise
and clinical judgment [53]. Endoscopic or surgical treatment decision after rebleeding obvi‐
ously depends on the age, associated diseases and bleeding stigmata. Thus, a patient duodenal
ulcer with a giant rear face with stigmata of recent hemorrhage requires surgical intervention,
while a young patient without leather rot associated with a small curvature gastric ulcer on
endoscopy can be restated. “Second-look” endoscopy is controversial, published studies have
demonstrated only a smaller proportion of rebleeding, but the same survival and required
surgical intervention [55]. Repeat endoscopy is indicated in patients with clinical suspicion of
rebleeding (hematemesis, melena, tachycardia, decreased pressure). Although some patients
require direct surgical intervention, the majority of repeat endoscopy are indicated to confirm
rebleeding [53].
5.6. Vascular malformations
Vascular malformations laid comprise several entities: angiodysplasia (Figure 3), telangiecta‐
sia (Osler-Weber disease, Rendu syndrome or Turner CREST) phlebectasia (varicosities and
well-defined circular) and hemangiomas. Moreover, although endoscopically identified as a
possible cause of bleeding, they cannot be differentiated based on endoscopic appearance. The
diagnosis of leather rot are used and other imaging techniques such as angiography or, more
recently, positron endoscopic optical coherence Doppler (Doppler optical coherence tomog‐
raphy) is a method that detects different vascular patterns [56].
Angiodysplasia (Figure 3) are found within 5% of gastrointestinal bleeding higher, being more
common in the stomach, duodenum and proximal portion small intestine. Prevalence of
angiodysplasia appears to be greater in patients with chronic renal insufficiency. Endoscopic
treatment was performed along time with different methods (injection, multipolar electrocoa‐
Figure 3. Gastric angiodysplasia and duodenal ulcer
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gulation and bimechanical methods), but the degree of success is variable. Rebleeding is
frequently encountered by all forms of treatment, due to the presence of lesions that are
multifocal, inaccessible and the potential for the formation of new lesions [57]. The most
common method remains bipolar coagulation and laser treatment Nd: YAG [58]. Recent
studies have indicated the usefulness of eradication lesions using argon plasma coagulation
(APC) [59]. Isolated gastric angiodysplasia can be treated with elastic ligatures [60]. Multiple
other non-endoscopic treatments of angiodysplasia were tested with variable results: hormo‐
nal medication, administration of octreotide, antiangiogenic agents used in oncology and
(thalidomide, lenalidomide bevacizumab, etc.), the management of acid aminocaproic [61-63].
Endoscopic treatment reduces the rebleeding and transfusion needs. Surgery is an indication
only in cases with severe or acute hemorrhage in patients with severe anemia; persistent
bleeding in the intestinal segment is usually well defined.
5.7. Gastrointestinal tumors
Gastrointestinal tumors are a common cause of non-variceal bleeding, most cases the gastric
adenocarcinomas (Figure 4). Other tumors encountered are ampullary or duodenal tumor
invasion of pancreatic head cancers, submucosal or metastatic tumors. Immediate survival of
these patients is similar to other patients with non-variceal HDS, but prognosis term is
reserved. Endoscopic treatment has limited benefits; endoscopic hemostasis has a role to delay
until the intervention is definitive or palliative surgery. Inoperable patients may benefit from
palliative treatment with laser or argon plasma.
5.8. Esophagitis and esophageal ulcers or contravention of junction esogastric
Reflux esophagitis occurs due to prolonged contact of contents of peptic esophageal mucosa
and being characterized pathologically by esophageal mucosal inflammatory lesions that are
Figure 4. Gastric adenocarcinoma
Endoscopic Treatment of Gastrointestinal Bleedings
http://dx.doi.org/10.5772/61192
87
potential sources of bleeding [64]. 5% of reflux esophagitis and be complicated by gastroin‐
testinal bleeding. It can be located at esogastric junction or mucosal metaplasia of Barrett’s
esophagus, requiring repeat biopsies to exclude esophageal cancer that can develop within the
lesion. Reflux esophagitis occurs frequently in the presence of hiatal hernia. In the context of
the presence of hiatal hernias, large Cameron ulcers can occur, which are longitudinal ulcers
identified in approximately 1/3 of patients [65].
Esophagitis can occur during or after radiation treatment for lymphoma, lung cancer, breast
cancer or other mediastinal malignancies. These patients have increased risk of developing
esophageal cancer in a few years. Acute necrotizing esophagitis (black esophagus) is a
particular form of severe damage to the esophagus, rarely met, but frequently associated with
upper gastrointestinal bleeding. It generally appears in patients with severe general condition,
with cancer or after severe infections.
5.9. Erosive gastritis and hemorrhagic gastropathy
Erosive  gastritis  stress  and  hemorrhagic  gastropathy  accounts  for  25% of  cases  of  non-
variceal bleedings [64]. Stress gastritis generally occurs in patients with shock, burns, sepsis,
severe trauma, multiple organ insufficiency after complicated surgical interventions and so
on.  In  general,  stress  gastritis  is  characterized  by  the  occurrence  of  multiple  superficial
gastric ulcers, with diffuse bleeding. These lesions are located initially at the back of the
gastric body then extend throughout the gastric surface. In most patients the bleeding stops
spontaneously,  but  medical  treatment  and  angiographic  or  surgical  excision  may  be
necessary to a small fraction of patients [64]. Prophylaxis of stress gastritis is much more
important,  being  necessary  to  prevent  bleeding  by  increasing  digestive  intragastric  pH
above 4.  Hemorrhagic erosive gastropathy consists  of  multiple erosive and subepithelial
bleeding, endoscopic views, which may cause digestive bleeding. These injuries occur in
different clinical circumstances, the most common being the intake of NSAIDs, aspirin and
alcohol. Bleeding from gastric and gastropathy have low severity, stop spontaneously, and
mortality is relatively low. Stop the NSAID or aspirin and patients are treated with standard
PPI doses. Endoscopic treatment is not necessary.
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